{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:37:48Z","timestamp":1786361868336,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.diagmicrobio.2025.116961","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T15:41:47Z","timestamp":1750261307000},"page":"116961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prediction of treatment success in patients with Enterococcus faecium bacteremia using vancomycin AUC24\/MIC ratio: A multicenter retrospective study"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4606-7150","authenticated-orcid":false,"given":"Yuki","family":"Hanai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Hanawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiju","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taito","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohei","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Uekusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riku","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Asakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Namiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Enoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.diagmicrobio.2025.116961_bib0001","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/microorganisms8081118","article-title":"from harmless bacteria to a pathogen","volume":"8","author":"Ramos","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.diagmicrobio.2025.116961_bib0002","series-title":"Enterococci: from commensals to leading causes of drug resistant infection [Internet]","article-title":"Enterococcal disease, epidemiology, and implications for treatment","author":"Agudelo Higuita","year":"2014"},{"key":"10.1016\/j.diagmicrobio.2025.116961_bib0003","doi-asserted-by":"crossref","unstructured":"Fiore E, Van Tyne D, Gilmore MS. Pathogenicity of enterococci 2019;7(4): https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0053-2018.","DOI":"10.1128\/microbiolspec.GPP3-0053-2018"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2025.116961_bib0004","article-title":"Temporal and geographic variation in antimicrobial susceptibility and resistance patterns of enterococci: results from the SENTRY antimicrobial surveillance program, 1997-2016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116961_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.726","article-title":"The nephrotoxicity of vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2025.116961_bib0006","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","article-title":"Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review","volume":"68","author":"Elyasi","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.116961_bib0007","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116961_bib0008","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/pharmaceutics14030489","article-title":"Clinical practice guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"14","author":"Matsumoto","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116961_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146224","article-title":"Association between the AUC0-24\/MIC ratio of vancomycin and its clinical effectiveness: a systematic review and meta-analysis","volume":"11","author":"Men","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116961_bib0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/AAC.48.1.63-68.2004","article-title":"In vivo pharmacodynamic activity of daptomycin","volume":"48","author":"Safdar","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.116961_bib0011","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/AAC.46.11.3484-3489.2002","article-title":"In vivo pharmacodynamics of a new oxazolidinone (linezolid)","volume":"46","author":"Andes","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2025.116961_bib0012","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s11095-021-03030-y","article-title":"Performance of area under the concentration-time curve estimations of vancomycin with limited sampling by a newly developed web application","volume":"38","author":"Oda","year":"2021","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.116961_bib0013","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1111\/cts.13626","article-title":"Model-informed precision dosing of vancomycin for rapid achievement of target area under the concentration-time curve: a simulation study","volume":"16","author":"Oda","year":"2023","journal-title":"Clin Transl Sci"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2025.116961_bib0014","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00007691-199804000-00003","article-title":"Population pharmacokinetics of vancomycin in Japanese adult patients","volume":"20","author":"Yasuhara","year":"1998","journal-title":"Ther Drug Monit"},{"issue":"15","key":"10.1016\/j.diagmicrobio.2025.116961_bib0015","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/archinternmed.2011.318","article-title":"Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms","volume":"171","author":"Schuetz","year":"2011","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2025.116961_bib0016","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s10096-016-2691-z","article-title":"Enhanced loading regimen of teicoplanin is necessary to achieve therapeutic pharmacokinetics levels for the improvement of clinical outcomes in patients with renal dysfunction","volume":"35","author":"Ueda","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116961_bib0017","first-page":"31","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.diagmicrobio.2025.116961_bib0018","doi-asserted-by":"crossref","DOI":"10.1086\/491712","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"42","author":"Rybak","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116961_bib0019","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12879-021-05858-6","article-title":"The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing","volume":"21","author":"Tsutsuura","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116961_bib0020","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01602-17","article-title":"Pharmacokinetic\/pharmacodynamic determinants of vancomycin efficacy in enterococcal bacteremia","volume":"62","author":"Jumah","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2025.116961_bib0021","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3390\/pharmaceutics13091378","article-title":"A monocentric retrospective study of AUC\/MIC ratio of vancomycin associated with clinical outcomes and nephrotoxicity in patients with enterococcal infections","volume":"13","author":"Katip","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116961_bib0022","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12879-022-07668-w","article-title":"Pharmacokinetic\/pharmacodynamic parameters of vancomycin for predicting clinical outcome of enterococcal bacteremia","volume":"22","author":"Nham","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2025.116961_bib0023","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccc.2007.12.012","article-title":"Vancomycin revisited: a reappraisal of clinical use","volume":"24","author":"Cunha","year":"2008","journal-title":"Crit Care Clin"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2025.116961_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074734","article-title":"Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes","volume":"8","author":"Gudiol","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2025.116961_bib0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijid.2014.02.012","article-title":"Incidence, risk factors, and outcomes for Enterococcus spp. Blood stream infections: a population-based study","volume":"26","author":"Billington","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2025.116961_bib0026","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40780-019-0138-2","article-title":"Association between vancomycin pharmacokinetic\/pharmacodynamic parameters, patient characteristics, and mortality in patients with bacteremia caused by vancomycin-susceptible Enterococcus faecium: a single-center retrospective study","volume":"5","author":"Nakakura","year":"2019","journal-title":"J Pharm Health Care Sci"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.116961_bib0027","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.3390\/antibiotics12111577","article-title":"Assessing clinical outcomes of vancomycin treatment in adult patients with vancomycin-susceptible Enterococcus faecium bacteremia","volume":"12","author":"Sasano","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2025.116961_bib0028","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/0897190014546114","article-title":"Vancomycin nephrotoxicity: a review","volume":"27","author":"Mergenhagen","year":"2014","journal-title":"J Pharm Pract"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2025.116961_bib0029","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/phar.1638","article-title":"Vancomycin trough concentration as a predictor of clinical outcomes in patients with Staphylococcus aureus bacteremia: a meta-analysis of observational studies","volume":"35","author":"Prybylski","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.116961_bib0030","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1177\/1060028017720946","article-title":"Intravenous vancomycin associated with the development of nephrotoxicity in patients with class III obesity","volume":"51","author":"Choi","year":"2017","journal-title":"Ann Pharmacother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.116961_bib0031","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/cid\/ciz051","article-title":"Vancomycin area under the curve and acute kidney injury: a meta-analysis","volume":"69","author":"Aljefri","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116961_bib0032","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.01653-13","article-title":"Are vancomycin trough concentrations adequate for optimal dosing?","volume":"58","author":"Neely","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.116961_bib0033","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s11095-024-03781-4","article-title":"Identification of patients who require two-point blood sampling for the peak and trough values rather than one-point blood sampling for the trough value for the evaluation of AUC of vancomycin using bayesian estimation","volume":"41","author":"Suzuki","year":"2024","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116961_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325002846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325002846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:26:01Z","timestamp":1786361161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889325002846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0732889325002846"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116961","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of treatment success in patients with Enterococcus faecium bacteremia using vancomycin AUC24\/MIC ratio: A multicenter retrospective study","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116961"}}